CellGenix Technologie Transfer GmbH
www.cellgenix.com

CellGenix Technologie Transfer GmbH
Advanced Cell Therapies – from Lab to Clinic

CellGenix Technologie Transfer GmbH is a well-established, innovative and market-driven biopharmaceutical company headquartered in Freiburg, Germany. CellGenix, which was founded in 1994 as a spin-off of the University Medical Center Freiburg, currently has more than 45 employees. In 1995 CellGenix established the first GMP-compliant cell processing facility in Europe. CellGenix develops, manufactures and markets individualized and tailor-made cell and protein therapeutics for cancer treatment and orthopedic surgery, as well as high-quality tools for therapeutic ex vivo cell processing.

Innovative research and development

CellGenix's research focuses on stem cell therapy for the regeneration of tissues and organs, cancer immunotherapy and the development of GMP-grade ex vivo cell processing tools, like kit systems, cytokines and serum-free media. A patient-specific idiotype vaccine (IdioVax®) against Non-Hodgkin's B-cell lymphoma is already in a Phase II clinical trial which is being conducted in collaboration with Freiburg's University Medical Center and the Center for Clinical Research.

Cutting edge products and services

Together with its distribution partners CellGenix markets a variety of superior products and services for clinical cell therapy applications: cord blood cell processing and banking, autologous chondrocyte transplantation as well as GMP-grade cytokines, serum-free media and kit systems for therapeutic ex vivo cell processing. Additionally, we offer specialized contract manufacturing services.

GMP-compliant cell processing for therapeutic applications:

GMP cell processing tools for therapeutic ex vivo cell culture:

Safety and superior quality

CellGenix's extensive experience has enabled the company to build up a strong portfolio of products in the field of GMP-compliant production of cell and protein therapeutics. Continuous interaction with various competent authorities assures compliance with highest quality standards in the fields of individual biopharmaceuticals and cell based medicinal products. Since the fall 2001, with the expansion of its office and production complex near the Freiburg airport, CellGenix has at its disposal one of the most technologically advanced GMP facilities for the processing and manufacturing of individual cell and protein therapeutics.

CellGenix Technologie Transfer GmbH
Am Flughafen 16
70108 Freiburg
Germany

Phone: +49 761 – 88889 0
Fax: +49 761 – 88889 800
Internet: www.cellgenix.com
Email: info@cellgenix.com